A study in mice has identified 865 gene targets of the fragile X mental retardation protein (FMRP)…
Aisha I Abdullah PhD
Aisha Abdullah received a B.S. in biology from the University of Houston and a Ph.D. in neuroscience from Weill Cornell Medical College, where she studied the role of microRNA in embryonic and early postnatal brain development. Since finishing graduate school, she has worked as a science communicator making science accessible to broad audiences.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Aisha I Abdullah PhD
Zynerba Pharmaceuticals announced plans to open a pivotal clinical trial next year for its cannabidiol (CBD)…
Allos Pharma has obtained exclusive rights to arbaclofen, a potential treatment for fragile X…
Actinogen Medical announced plans to open a Phase 2 trial of its experimental oral therapy…